Featured Article

The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451

Recent Translated Articles from The Oncologist

Volume 23: Number 6, June 2018

Clinical Trial Results

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer
Joachim von Pawel, David R. Spigel, Thomas Ervin, György Losonczy, Fabrice Barlesi, Erzsébet Juhász, Maria Anderson, Bruce McCall, Eric Wakshull, Priti Hegde, Weilan Ye, Daniel Chen, Ilsung Chang, Ina Rhee, Martin Reck
The Oncologist 2018; 23:654-e58; first published on February 7, 2018; doi:10.1634/theoncologist.2017-0690

A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer
Xiao X. Wei, Adam P. Siegel, Rahul Aggarwal, Amy M. Lin, Terence W. Friedlander, Lawrence Fong, Won Kim, Mirela Louttit, Emily Chang, Li Zhang, Charles J. Ryan
The Oncologist 2018; 23:656-e64; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0624

A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Anthony Tolcher, Keith Flaherty, Geoffrey I. Shapiro, Jordan Berlin, Thomas Witzig, Thomas Habermann, Andrea Bullock, Edwin Rock, Agnes Elekes, Chester Lin, Dusan Kostic, Naoto Ohi, Drew Rasco, Kyriakos P. Papadopoulos, Amita Patnaik, Lon Smith, Gregory M. Cote
The Oncologist 2018; 23:658-e72; first published on March 6, 2018; doi:10.1634/theoncologist.2017-0325

Breast Cancer

Emerging Perspectives on mTOR Inhibitor‐Associated Pneumonitis in Breast Cancer
Ricardo H. Alvarez, Rabih I. Bechara, Michael J. Naughton, Javier A. Adachi, James M. Reuben
The Oncologist 2018; 23:660-669; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0343

Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
Paula Cabrera‐Galeana, Wendy Muñoz‐Montaño, Fernando Lara‐Medina, Alberto Alvarado‐Miranda, Victor Pérez‐Sánchez, Cynthia Villarreal‐Garza, R. Marisol Quintero, Fany Porras‐Reyes, Enrique Bargallo‐Rocha, Ignacio Del Carmen, Alejandro Mohar, Oscar Arrieta
The Oncologist 2018; 23:670-678; first published on February 28, 2018; doi:10.1634/theoncologist.2017-0396

Gastrointestinal Cancer

A Curative‐Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single‐Institutional Experience
Benny Johnson, Zhaohui Jin, Michael G. Haddock, Christopher L. Hallemeier, James A. Martenson, Rory L. Smoot, David W. Larson, Eric J. Dozois, David M. Nagorney, Axel Grothey
The Oncologist 2018; 23:679-685; first published on February 14, 2018; doi:10.1634/theoncologist.2017-0456

Hematologic Malignancies

Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B‐Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment
Hui Liu, Chun‐Li Zhang, Ru Feng, Jiang‐Tao Li, Yuan Tian, Ting Wang
The Oncologist 2018; 23:722-729; first published on January 9, 2018; doi:10.1634/theoncologist.2017-0361

Symptom Management and Supportive Care

Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension
Rahul A. Sheth, Sharjeel H. Sabir, Philip Parmet, Roshon Amin, Joshua D. Kuban, Steven Y. Huang, Armeen Mahvash, David Fogelman, Milind Javle, Michael J. Wallace
The Oncologist 2018; 23:712-718; first published on December 28, 2017; doi:10.1634/theoncologist.2017-0337